CN104193688A - 厄洛替尼中间体的合成方法 - Google Patents
厄洛替尼中间体的合成方法 Download PDFInfo
- Publication number
- CN104193688A CN104193688A CN201410446651.3A CN201410446651A CN104193688A CN 104193688 A CN104193688 A CN 104193688A CN 201410446651 A CN201410446651 A CN 201410446651A CN 104193688 A CN104193688 A CN 104193688A
- Authority
- CN
- China
- Prior art keywords
- reaction
- synthetic method
- bis
- methoxy ethoxy
- ammonia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- PMQWTUWLIGJTQD-UHFFFAOYSA-N COCCOc(cc(c(N=CN1)c2)C1=O)c2OCCOC Chemical compound COCCOc(cc(c(N=CN1)c2)C1=O)c2OCCOC PMQWTUWLIGJTQD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410446651.3A CN104193688A (zh) | 2014-09-04 | 2014-09-04 | 厄洛替尼中间体的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410446651.3A CN104193688A (zh) | 2014-09-04 | 2014-09-04 | 厄洛替尼中间体的合成方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104193688A true CN104193688A (zh) | 2014-12-10 |
Family
ID=52079098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410446651.3A Pending CN104193688A (zh) | 2014-09-04 | 2014-09-04 | 厄洛替尼中间体的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104193688A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109096136A (zh) * | 2018-08-27 | 2018-12-28 | 山东金城医药化工有限公司 | 厄洛替尼中间体化合物及其精制方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002293773A (ja) * | 2001-03-30 | 2002-10-09 | Sumika Fine Chemicals Co Ltd | キナゾリン誘導体の製造方法 |
EP1330444B1 (en) * | 2000-11-01 | 2011-03-23 | Millennium Pharmaceuticals, Inc. | Nitrogenous heterocyclic compounds and process for making them |
CN102827086A (zh) * | 2012-08-03 | 2012-12-19 | 浙江理工大学 | 一种4-氯-6,7-二-(2-甲氧基乙氧基)-喹唑啉的制备方法 |
CN102863395A (zh) * | 2011-07-04 | 2013-01-09 | 北京六盛合医药科技有限公司 | 一种厄洛替尼的合成新方法 |
-
2014
- 2014-09-04 CN CN201410446651.3A patent/CN104193688A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1330444B1 (en) * | 2000-11-01 | 2011-03-23 | Millennium Pharmaceuticals, Inc. | Nitrogenous heterocyclic compounds and process for making them |
JP2002293773A (ja) * | 2001-03-30 | 2002-10-09 | Sumika Fine Chemicals Co Ltd | キナゾリン誘導体の製造方法 |
CN102863395A (zh) * | 2011-07-04 | 2013-01-09 | 北京六盛合医药科技有限公司 | 一种厄洛替尼的合成新方法 |
CN102827086A (zh) * | 2012-08-03 | 2012-12-19 | 浙江理工大学 | 一种4-氯-6,7-二-(2-甲氧基乙氧基)-喹唑啉的制备方法 |
Non-Patent Citations (1)
Title |
---|
原友志,等: "盐酸厄洛替尼合成路线图解", 《中国医药工业杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109096136A (zh) * | 2018-08-27 | 2018-12-28 | 山东金城医药化工有限公司 | 厄洛替尼中间体化合物及其精制方法 |
CN109096136B (zh) * | 2018-08-27 | 2020-11-03 | 山东金城医药化工有限公司 | 厄洛替尼中间体化合物及其精制方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104496983A (zh) | 一种帕博西尼的制备方法 | |
CN102924434B (zh) | 一种右旋雷贝拉唑钠单水合物晶型及其制备方法 | |
CN104193688A (zh) | 厄洛替尼中间体的合成方法 | |
WO2022161469A1 (zh) | 一种硫代乙内酰脲药物用中间体及其制备方法与用途 | |
CN109134430B (zh) | 一种hplc法制备雷贝拉唑杂质的方法 | |
CN103755648A (zh) | 一种吉非替尼的新杂质及其制备方法 | |
CN108203437A (zh) | 两种替吡嘧啶杂质制备方法与应用 | |
CN104910002B (zh) | 一种地佐辛关键中间体的制备方法 | |
CN105384686B (zh) | 一种博舒替尼结晶方法 | |
CN103319548B (zh) | 一种蔗糖-6-乙酸酯的提纯方法 | |
CN102050825B (zh) | 制备培美曲塞二钠2.5水结晶的方法 | |
CN101941971B (zh) | 一种吴茱萸碱的合成方法 | |
CN104744530B (zh) | 一种天麻衍生物晶型及其制备方法、制剂与应用 | |
CN103319422A (zh) | 一种吉非替尼新晶型及其制备方法 | |
CN102731383A (zh) | 一种3-甲基-6-氯-2-甲酸甲酯吡啶的合成方法 | |
CN104177301B (zh) | 一种右丙亚胺的制备方法 | |
CN105001166A (zh) | 一种厄洛替尼的新杂质及其制备方法 | |
CN105001197B (zh) | 一种阿格列汀衍生物ⅰ及其制备方法与应用 | |
CN104910080B (zh) | 一种厄洛替尼相关物质及其制备方法 | |
CN106632081A (zh) | 一种5‑氯‑6‑(氯甲基)尿嘧啶及其制备方法 | |
CN112457293A (zh) | Tbtu在制备抗癌药物中的用途 | |
CN111320586A (zh) | 一种厄洛替尼的合成方法 | |
CN104672243A (zh) | 维格列汀降解杂质的制备方法 | |
CN104788482B (zh) | 一种制备2-氨基嘧啶-5-硼酸频那醇酯的方法 | |
CN103450097A (zh) | 一种高纯度a晶型盐酸埃罗替尼的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Tang Dan Inventor after: Sun Zuguang Inventor after: Fan Shaolong Inventor after: Zheng Guorong Inventor after: Shang Yongyan Inventor after: Dong Jin Inventor after: Zhao Liqiang Inventor before: Tang Dan Inventor before: Sun Zuguang Inventor before: Fan Shaolong Inventor before: Zheng Guorong Inventor before: Shang Yongyan Inventor before: Dong Jin Inventor before: Zhao Liqiang |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141210 |